| Basics |
CareDx, Inc.
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
|
| IPO Date: |
July 17, 2014 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$910.93M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.64 | 3.10%
|
| Avg Daily Range (30 D): |
$0.57 | 3.39%
|
| Avg Daily Range (90 D): |
$0.64 | 3.22%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.49M |
| Avg Daily Volume (30 D): |
.96M |
| Avg Daily Volume (90 D): |
.78M |
| Trade Size |
| Avg Trade Size (Sh.): |
77 |
| Avg Trade Size (Sh.) (30 D): |
64 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Inst.Trades: |
3,090 |
| Avg Inst. Trade: |
$2.4M |
| Avg Inst. Trade (30 D): |
$2.27M |
| Avg Inst. Trade (90 D): |
$2.16M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.89M |
| Avg Closing Trade (30 D): |
$2.76M |
| Avg Closing Trade (90 D): |
$2.61M |
| Avg Closing Volume: |
115.4K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$-.19
|
$-.14
|
|
Diluted EPS
|
|
$-.19
|
$-.14
|
|
Revenue
|
$
|
$ 84.69M
|
$ 82.88M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -10.35M
|
$ -7.41M
|
|
Operating Income / Loss
|
$
|
$ -13.37M
|
$ -10.49M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ -25.9M
|
$ -.46M
|
|
PE Ratio
|
|
|
|
|
